![]() Financial Daily from THE HINDU group of publications Wednesday, Nov 16, 2005 |
|
|
|
|
|
|
|
Industry & Economy
-
Events Govt may make clinical research part of medical college curriculum Our Bureau
New Delhi , Nov. 15 THE Government plans to make clinical research part of the course structure at medical schools in the next five years. This was stated by Dr M.K. Bhan, Secretary, Department of Biotechnology. He was addressing the inaugural session of the three-day `Bio-Business Summit 2005 Global Clinical Trials in India: Challenges and Opportunities,' organised on Monday by the Federation of Indian Chamber of Commerce and Industry (FICCI), Department of Biotechnology, Ministry of Health and Family Welfare and Indian Council of Medical Research (ICMR). He pointed out that it was necessary to have human resource creation strategies for clinical research in India and a proper assessment of the training needs for researchers. Dr Bhan said that ICMR and the Ministry of Science and Technology would also overhaul the medical school research system to produce skilled, motivated and ethical professionals in biotechnology research. The Minister of State for Health and Family Welfare, Ms Panabaka Lakshmi, said that good clinical practices, while conducting trials, have to be a shared responsibility of sponsors, clinical investigators, ethics committees and regulatory bodies. "As our share in global clinical research increases, the challenges would have to be met along with the opportunities thrown up by this intellectual activity. "The need of the hour is to identify the deficiencies and prepare for the challenges much in advance and to address them in a speedy and effective manner," she said.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|